| scholarly article | Q13442814 |
| P356 | DOI | 10.1191/0961203303LU339OA |
| P953 | full work available at URL | http://journals.sagepub.com/doi/pdf/10.1191/0961203303lu339oa |
| P698 | PubMed publication ID | 12729054 |
| P2093 | author name string | G. Szegedi | |
| E. Kiss | |||
| L. Muszbek | |||
| K. Veres | |||
| G. Lakos | |||
| P. Soltész | |||
| P2860 | cites work | British Journal of Rheumatology | Q27709787 |
| Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus | Q28261335 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| The Journal of Rheumatology | Q7743623 | ||
| The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients | Q33371184 | ||
| 'Primary', 'secondary' and other variants of the antiphospholipid syndrome | Q33490042 | ||
| Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice | Q33491319 | ||
| Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients | Q33502956 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Antiphospholipid syndrome and thrombosis | Q33709559 | ||
| Inflammation-mediated rheumatic diseases and atherosclerosis | Q35549285 | ||
| The antiphospholipid syndrome: ten years on. | Q40711282 | ||
| Immunology of the antiphospholipid antibody syndrome | Q41116413 | ||
| Hyperlipidemia and the rheumatic diseases. | Q41241433 | ||
| Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus | Q68008000 | ||
| Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis | Q70529807 | ||
| Coronary arterial disease in systemic lupus erythematosus; quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years | Q70715027 | ||
| The use of an anti-beta 2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis | Q70862020 | ||
| Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry | Q71112355 | ||
| Activated protein C resistance in patients with anti-beta 2 glycoprotein I antibodies | Q71869953 | ||
| Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients | Q72764443 | ||
| Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain | Q73289480 | ||
| The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis | Q78108902 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatology | Q327657 |
| antiphospholipid syndrome | Q582207 | ||
| P304 | page(s) | 302-307 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients | |
| P478 | volume | 12 |
| Q33398476 | A case of catastrophic antiphospholipid antibody syndrome complicated with systemic lupus erythematosus, double positive for anti-cardiolipin/β₂ glycoprotein I and anti-phosphatidylserine/prothrombin autoantibodies |
| Q43901099 | Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients |
| Q38108396 | Anti-β2-glycoprotein I antibodies |
| Q37378103 | Antiphospholipid antibodies in rheumatoid arthritis: identifying the dominoes |
| Q37319989 | Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings |
| Q64262888 | Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form |
| Q38152823 | Cardiovascular comorbidities in antiphospholipid syndrome |
| Q56452046 | Cardiovascular disease in the antiphospholipid syndrome |
| Q84774055 | Catastrophic antiphospholipid syndrome: first signs in the neonatal period |
| Q28222458 | Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up |
| Q36434125 | Cognitive dysfunction in the patient with antiphospholipid antibodies: considerations for cause and treatment |
| Q37283020 | Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases. |
| Q45922457 | Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. |
| Q90467060 | Intra-cardiac thrombus in antiphospholipid antibody syndrome: An unusual cause of fever of unknown origin with review of literature |
| Q41480353 | Multiple recurrent stent thrombosis in a patient with coexisting clopidogrel resistance and increased anticardiolipin antibodies: a case report. |
| Q40503099 | Renal artery thrombosis in a pediatric case of systemic lupus erythematosus without antiphospholipid antibodies |
| Q30485152 | Right atrial thrombus mimicking myxoma with pulmonary embolism in a patient with systemic lupus erythematosus and secondary antiphospholipid syndrome |
| Q45302065 | Thrombophilic risk factors in patients with severe carotid atherosclerosis |
Search more.